Luminex Plc · CSELK:LUMX.N0000

Luminex — Corporate Update (January 2008)

7 slides from Luminex's corporate update, Jan 3, 2008

  1. Slide 1: xTAG Respiratory Viral Panel

    xTAG(tm) Respiratory Viral Panel Patrick J. Balthrop Luminex Corporation, President and Chief Executive Officer January 3, 2008

  2. Slide 2: Safe Harbor

    Safe Harbor Certain statements made during the course of this presentation may not be purely historical and consequently may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statements made regarding the company's

  3. Slide 3: xTAG RVP has received 510(k) clearance from the FDA

    xTAG Respiratory Viral Panel xTAG(tm) RVP has received 510(k) clearance from the FDA Respiratory Viral Panel 3

  4. Slide 4: xTAG RVP First test of its kind cleared by FDA

    xTAG RVP First test of its kind cleared by FDA First multiplexed nucleic acid test for respiratory viruses cleared for in vitro diagnostic use by FDA First FDA-cleared test of any kind for influenza A subtyping and metapneumovirus First FDA-cleared molecular test for adenovirus Fast and specific tes

  5. Slide 5: Viruses and Subtypes

    12 Viruses and Subtypes Adenovirus Influenza A Influenza H1 Influenza H3 Influenza B Metapneumovirus Parainfluenza 1 Parainfluenza 2 Parainfluenza 3 Respiratory Syncytial Virus (RSV) A Respiratory Syncytial Virus (RSV) B Rhinovirus 5

  6. Slide 6: Source: US CDC, 2007 Flu Season Statistics

    Source: US CDC, 2007 Flu Season Statistics, U.S. 6

  7. Slide 7: Luminex

    Luminex. XNTAG Respiratory Viral Panel

Luminex — Corporate Update (January 2008) on 6ix